A2A adenosine receptor overexpression and functionality, as well as TNF-α levels, correlate with motor symptoms in Parkinson's disease

Katia Varani, Fabrizio Vincenzi, Alice Tosi, Stefania Gessi, Ilaria Casetta, Gino Granieri, Patrik Fazio, Edward Leung, Stephen MacLennan, Enrico Granieri, Pier Andrea Borea

Research output: Contribution to journalArticle

82 Citations (Scopus)

Abstract

The antagonistic interaction between adenosine and dopamine receptors could have important pathophysiological and therapeutic implications in Parkinson's disease (PD). The primary aim of this study was to investigate the expression, affinity, and density of A1, A2A, A2B, and A3 adenosine receptors (ARs) and D2 dopamine receptors (D2Rs) in PD. An increase in A2AAR density in putamen was found. The presence and functionality of ARs in human lymphocyte and neutrophil membranes from patients with PD revealed a specific A2AAR alteration compared with healthy subjects. A statistically significant linear correlation among the A2AAR density, functionality, or tumor necrosis factor-α (TNF-α) levels and Unified Parkinson's Disease Rating Scale (UPDRS) motor score was reported. Adenosine concentration and TNF-α levels were increased in plasma of patients with PD. In rat adrenal pheochromocytoma (PC12) cells, a widely useful model, adenosine antagonists decreased dopamine uptake, and an opposite effect was mediated by A2A agonists. This is the first report showing the presence of an A2AAR alteration in putamen in PD that mirrors a similar up-regulation in human peripheral blood cells. Moreover, the correlation found between A2AAR density or A2A agonist potency and UPDRS motor score highlights the central role of A2AARs in the pharmacological treatment of PD.-Varani, K., Vincenzi, F., Tosi, A., Gessi, S., Casetta, I., Granieri, G., Fazio, P., Leung, E., MacLennan, S., Granieri, E., Borea, P. A. A2A adenosine receptor overexpression and functionality, as well as TNF-α levels, correlate with motor symptoms in Parkinson's disease.

Original languageEnglish
Pages (from-to)587-598
Number of pages12
JournalFASEB Journal
Volume24
Issue number2
DOIs
Publication statusPublished - Feb 2010

Fingerprint

Adenosine A2A Receptors
Parkinson Disease
Tumor Necrosis Factor-alpha
Purinergic P1 Receptors
Putamen
Adenosine
Adenosine A2B Receptors
Adenosine A3 Receptors
Megestrol Acetate
Adenosine A1 Receptors
Dopamine Antagonists
Lymphocytes
Dopamine D2 Receptors
PC12 Cells
Dopamine Receptors
Pheochromocytoma
Rats
Dopamine
Blood Cells
Healthy Volunteers

Keywords

  • D dopamine receptors
  • Human lymphocytes and neutrophils
  • Human putamen

ASJC Scopus subject areas

  • Biochemistry
  • Biotechnology
  • Genetics
  • Molecular Biology
  • Medicine(all)

Cite this

A2A adenosine receptor overexpression and functionality, as well as TNF-α levels, correlate with motor symptoms in Parkinson's disease. / Varani, Katia; Vincenzi, Fabrizio; Tosi, Alice; Gessi, Stefania; Casetta, Ilaria; Granieri, Gino; Fazio, Patrik; Leung, Edward; MacLennan, Stephen; Granieri, Enrico; Borea, Pier Andrea.

In: FASEB Journal, Vol. 24, No. 2, 02.2010, p. 587-598.

Research output: Contribution to journalArticle

Varani, K, Vincenzi, F, Tosi, A, Gessi, S, Casetta, I, Granieri, G, Fazio, P, Leung, E, MacLennan, S, Granieri, E & Borea, PA 2010, 'A2A adenosine receptor overexpression and functionality, as well as TNF-α levels, correlate with motor symptoms in Parkinson's disease', FASEB Journal, vol. 24, no. 2, pp. 587-598. https://doi.org/10.1096/fj.09-141044
Varani, Katia ; Vincenzi, Fabrizio ; Tosi, Alice ; Gessi, Stefania ; Casetta, Ilaria ; Granieri, Gino ; Fazio, Patrik ; Leung, Edward ; MacLennan, Stephen ; Granieri, Enrico ; Borea, Pier Andrea. / A2A adenosine receptor overexpression and functionality, as well as TNF-α levels, correlate with motor symptoms in Parkinson's disease. In: FASEB Journal. 2010 ; Vol. 24, No. 2. pp. 587-598.
@article{7957eb992ea24013b0e6c9e34a8feeac,
title = "A2A adenosine receptor overexpression and functionality, as well as TNF-α levels, correlate with motor symptoms in Parkinson's disease",
abstract = "The antagonistic interaction between adenosine and dopamine receptors could have important pathophysiological and therapeutic implications in Parkinson's disease (PD). The primary aim of this study was to investigate the expression, affinity, and density of A1, A2A, A2B, and A3 adenosine receptors (ARs) and D2 dopamine receptors (D2Rs) in PD. An increase in A2AAR density in putamen was found. The presence and functionality of ARs in human lymphocyte and neutrophil membranes from patients with PD revealed a specific A2AAR alteration compared with healthy subjects. A statistically significant linear correlation among the A2AAR density, functionality, or tumor necrosis factor-α (TNF-α) levels and Unified Parkinson's Disease Rating Scale (UPDRS) motor score was reported. Adenosine concentration and TNF-α levels were increased in plasma of patients with PD. In rat adrenal pheochromocytoma (PC12) cells, a widely useful model, adenosine antagonists decreased dopamine uptake, and an opposite effect was mediated by A2A agonists. This is the first report showing the presence of an A2AAR alteration in putamen in PD that mirrors a similar up-regulation in human peripheral blood cells. Moreover, the correlation found between A2AAR density or A2A agonist potency and UPDRS motor score highlights the central role of A2AARs in the pharmacological treatment of PD.-Varani, K., Vincenzi, F., Tosi, A., Gessi, S., Casetta, I., Granieri, G., Fazio, P., Leung, E., MacLennan, S., Granieri, E., Borea, P. A. A2A adenosine receptor overexpression and functionality, as well as TNF-α levels, correlate with motor symptoms in Parkinson's disease.",
keywords = "D dopamine receptors, Human lymphocytes and neutrophils, Human putamen",
author = "Katia Varani and Fabrizio Vincenzi and Alice Tosi and Stefania Gessi and Ilaria Casetta and Gino Granieri and Patrik Fazio and Edward Leung and Stephen MacLennan and Enrico Granieri and Borea, {Pier Andrea}",
year = "2010",
month = "2",
doi = "10.1096/fj.09-141044",
language = "English",
volume = "24",
pages = "587--598",
journal = "FASEB Journal",
issn = "0892-6638",
publisher = "FASEB",
number = "2",

}

TY - JOUR

T1 - A2A adenosine receptor overexpression and functionality, as well as TNF-α levels, correlate with motor symptoms in Parkinson's disease

AU - Varani, Katia

AU - Vincenzi, Fabrizio

AU - Tosi, Alice

AU - Gessi, Stefania

AU - Casetta, Ilaria

AU - Granieri, Gino

AU - Fazio, Patrik

AU - Leung, Edward

AU - MacLennan, Stephen

AU - Granieri, Enrico

AU - Borea, Pier Andrea

PY - 2010/2

Y1 - 2010/2

N2 - The antagonistic interaction between adenosine and dopamine receptors could have important pathophysiological and therapeutic implications in Parkinson's disease (PD). The primary aim of this study was to investigate the expression, affinity, and density of A1, A2A, A2B, and A3 adenosine receptors (ARs) and D2 dopamine receptors (D2Rs) in PD. An increase in A2AAR density in putamen was found. The presence and functionality of ARs in human lymphocyte and neutrophil membranes from patients with PD revealed a specific A2AAR alteration compared with healthy subjects. A statistically significant linear correlation among the A2AAR density, functionality, or tumor necrosis factor-α (TNF-α) levels and Unified Parkinson's Disease Rating Scale (UPDRS) motor score was reported. Adenosine concentration and TNF-α levels were increased in plasma of patients with PD. In rat adrenal pheochromocytoma (PC12) cells, a widely useful model, adenosine antagonists decreased dopamine uptake, and an opposite effect was mediated by A2A agonists. This is the first report showing the presence of an A2AAR alteration in putamen in PD that mirrors a similar up-regulation in human peripheral blood cells. Moreover, the correlation found between A2AAR density or A2A agonist potency and UPDRS motor score highlights the central role of A2AARs in the pharmacological treatment of PD.-Varani, K., Vincenzi, F., Tosi, A., Gessi, S., Casetta, I., Granieri, G., Fazio, P., Leung, E., MacLennan, S., Granieri, E., Borea, P. A. A2A adenosine receptor overexpression and functionality, as well as TNF-α levels, correlate with motor symptoms in Parkinson's disease.

AB - The antagonistic interaction between adenosine and dopamine receptors could have important pathophysiological and therapeutic implications in Parkinson's disease (PD). The primary aim of this study was to investigate the expression, affinity, and density of A1, A2A, A2B, and A3 adenosine receptors (ARs) and D2 dopamine receptors (D2Rs) in PD. An increase in A2AAR density in putamen was found. The presence and functionality of ARs in human lymphocyte and neutrophil membranes from patients with PD revealed a specific A2AAR alteration compared with healthy subjects. A statistically significant linear correlation among the A2AAR density, functionality, or tumor necrosis factor-α (TNF-α) levels and Unified Parkinson's Disease Rating Scale (UPDRS) motor score was reported. Adenosine concentration and TNF-α levels were increased in plasma of patients with PD. In rat adrenal pheochromocytoma (PC12) cells, a widely useful model, adenosine antagonists decreased dopamine uptake, and an opposite effect was mediated by A2A agonists. This is the first report showing the presence of an A2AAR alteration in putamen in PD that mirrors a similar up-regulation in human peripheral blood cells. Moreover, the correlation found between A2AAR density or A2A agonist potency and UPDRS motor score highlights the central role of A2AARs in the pharmacological treatment of PD.-Varani, K., Vincenzi, F., Tosi, A., Gessi, S., Casetta, I., Granieri, G., Fazio, P., Leung, E., MacLennan, S., Granieri, E., Borea, P. A. A2A adenosine receptor overexpression and functionality, as well as TNF-α levels, correlate with motor symptoms in Parkinson's disease.

KW - D dopamine receptors

KW - Human lymphocytes and neutrophils

KW - Human putamen

UR - http://www.scopus.com/inward/record.url?scp=76149098862&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=76149098862&partnerID=8YFLogxK

U2 - 10.1096/fj.09-141044

DO - 10.1096/fj.09-141044

M3 - Article

C2 - 19776336

AN - SCOPUS:76149098862

VL - 24

SP - 587

EP - 598

JO - FASEB Journal

JF - FASEB Journal

SN - 0892-6638

IS - 2

ER -